Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707018 | 1.00 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL16201691 | 0.99 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL16201689 | 0.99 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL29988966 | 0.99 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL29362566 | 0.99 | CNR2 (0.98) | CNR2CNR1 | |
| SCHEMBL11983320 | 0.96 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL29375790 | 0.96 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL6325191 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL29988839 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL6324025 | 0.89 | CNR2 (1.00) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122072257-A | Method for rapidly detecting poison in blood | 中国科学院大连化学物理研究所 | 2026-05-22 | — | — | CN | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| WO-2025137591-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PROMOTING ZINC SOLUBILIZATION AND ZINC UPTAKE IN PLANTS | Tenfold Technologies, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250177506-A1 | VACCINATION AND ANTIBODY GENERATION PLATFORM | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2025-06-05 | — | — | US | claimed |
| CN-119757587-A | Method for determining 15 new psychoactive substances in saliva by SLE-UPLC-MS/MS | 福州国际旅行卫生保健中心(福州海关口岸门诊部) | 2025-04-04 | — | — | CN | claimed |
| EP-4486336-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119136797-A | CB1Ligand conjugated compounds and uses thereof | 阿达尔克斯制药有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-115728280-B | On-site detection method for synthesizing cannabinoid JWH-018 | 中国科学院新疆理化技术研究所 | 2024-09-24 | — | — | CN | claimed |
| CN-115144489-A | Application of virtual template molecularly imprinted polymer in detection of synthesized casitone drugs | 大连海事大学 | 2022-10-04 | — | — | CN | claimed |
| CN-114945353-A | Controlled release formulations of highly lipophilic physiologically active substances | 埃德先进药物输送技术有限责任公司 | 2022-08-26 | — | — | CN | claimed |
| CN-114942239-A | Composition, kit and method for rapidly detecting synthetic cannabinoid in tobacco tar | 合肥市公安局刑事警察支队 | 2022-08-26 | — | — | CN | claimed |
| EP-4045007-A1 | CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES | ADD Advanced Drug Delivery Technologies, Ltd. (CH) | 2022-08-24 | — | — | EP | claimed |
| EP-4045014-A1 | CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES | ADD Advanced Drug Delivery Technologies, Ltd. (CH) | 2022-08-24 | — | — | EP | claimed |
| CN-114929197-A | Controlled release formulations of highly lipophilic physiologically active substances | 埃德先进药物输送技术有限责任公司 | 2022-08-19 | — | — | CN | claimed |
| EP-4041748-A1 | PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS | Universitat de Barcelona (ES) | 2022-08-17 | — | — | EP | claimed |
| CN-114641486-A | For reducing CB1Peptide compounds of side effects of receptor agonists | 庞培法布拉大学 | 2022-06-17 | — | — | CN | claimed |
| CN-114414548-A | SERS substrate and application thereof | 安徽中科赛飞尔科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| US-20220117932-A1 | Lecithin Vesicles | CannaClear Inc. (CA) | 2022-04-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | PDE9A, PDE3A, PDE2A | CNR2 204/4885CNR1 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.